FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2064232761> ?p ?o ?g. }

• W2064232761 endingPage "8" @default.
• W2064232761 startingPage "2" @default.
• W2064232761 abstract "After nearly four decades of clinical experience with the fluoropyrimidines, 5-fluorouracil (5-FU) remains an integral part of chemotherapy for colorectal cancer. A range of 5-FU treatment regimens with or without biochemical modulation are currently used and toxicity appears to be schedule dependent. The use of oral 5-FU was abandoned because of erratic absorption caused by varying levels of dihydropyrimidine dehydrogenase (DPD) found in the gastrointestinal tract. This effect may be overcome by administering agents that are converted to 5-FU or by inhibiting or inactivating DPD. Xeloda^® (capecitabine) was designed as an orally administered, selectively tumoractivated^TM cytotoxic agent which achieves higher levels of 5-FU in the primary tumor than in plasma or other tissues. The United States Food and Drug Administration (FDA) has approved Xeloda for use in patients with metastatic breast cancer resistant to paclitaxel and in whom further anthracycline therapy is contraindicated. Xeloda is also registered in Canada, Switzerland, Thailand and Argentina. In phase II clinical trials in colorectal cancer, Xeloda produced response rates of 21–24% and median time to disease progression of 127–230 days. Other oral agents in development for the treatment of colorectal cancer include tegafur/uracil plus oral leucovorin, S-1 and eniluracil plus oral 5-FU." @default.
• W2064232761 created "2016-06-24" @default.
• W2064232761 creator A5002818963 @default.
• W2064232761 creator A5040457482 @default.
• W2064232761 creator A5045902951 @default.
• W2064232761 creator A5051032137 @default.
• W2064232761 creator A5051520990 @default.
• W2064232761 creator A5069375794 @default.
• W2064232761 creator A5072207853 @default.
• W2064232761 date "1999-01-01" @default.
• W2064232761 modified "2023-10-04" @default.
• W2064232761 title "Fluoropyrimidines: A Critical Evaluation" @default.
• W2064232761 cites W1552036775 @default.
• W2064232761 cites W1580716972 @default.
• W2064232761 cites W1773171357 @default.
• W2064232761 cites W1849818006 @default.
• W2064232761 cites W1869910714 @default.
• W2064232761 cites W1888050314 @default.
• W2064232761 cites W1902766545 @default.
• W2064232761 cites W1905936368 @default.
• W2064232761 cites W1916841389 @default.
• W2064232761 cites W1941365207 @default.
• W2064232761 cites W1966159738 @default.
• W2064232761 cites W1966311999 @default.
• W2064232761 cites W1966992724 @default.
• W2064232761 cites W1972465013 @default.
• W2064232761 cites W1979110171 @default.
• W2064232761 cites W1996640078 @default.
• W2064232761 cites W2012005071 @default.
• W2064232761 cites W2044970916 @default.
• W2064232761 cites W2053203412 @default.
• W2064232761 cites W2057297505 @default.
• W2064232761 cites W2067509607 @default.
• W2064232761 cites W2077902459 @default.
• W2064232761 cites W2109218307 @default.
• W2064232761 cites W2110617366 @default.
• W2064232761 cites W2131926022 @default.
• W2064232761 cites W2141121384 @default.
• W2064232761 cites W2151967297 @default.
• W2064232761 cites W2155421004 @default.
• W2064232761 cites W2227311140 @default.
• W2064232761 cites W2267143225 @default.
• W2064232761 cites W2269247374 @default.
• W2064232761 cites W2396646859 @default.
• W2064232761 cites W2409196403 @default.
• W2064232761 cites W2411401384 @default.
• W2064232761 cites W2430678975 @default.
• W2064232761 cites W2473922399 @default.
• W2064232761 cites W2602544133 @default.
• W2064232761 cites W2991719273 @default.
• W2064232761 doi "https://doi.org/10.1159/000055262" @default.
• W2064232761 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10436410" @default.
• W2064232761 hasPublicationYear "1999" @default.
• W2064232761 type Work @default.
• W2064232761 sameAs 2064232761 @default.
• W2064232761 citedByCount "28" @default.
• W2064232761 countsByYear W20642327612012 @default.
• W2064232761 countsByYear W20642327612013 @default.
• W2064232761 countsByYear W20642327612016 @default.
• W2064232761 countsByYear W20642327612020 @default.
• W2064232761 countsByYear W20642327612021 @default.
• W2064232761 crossrefType "journal-article" @default.
• W2064232761 hasAuthorship W2064232761A5002818963 @default.
• W2064232761 hasAuthorship W2064232761A5040457482 @default.
• W2064232761 hasAuthorship W2064232761A5045902951 @default.
• W2064232761 hasAuthorship W2064232761A5051032137 @default.
• W2064232761 hasAuthorship W2064232761A5051520990 @default.
• W2064232761 hasAuthorship W2064232761A5069375794 @default.
• W2064232761 hasAuthorship W2064232761A5072207853 @default.
• W2064232761 hasConcept C121608353 @default.
• W2064232761 hasConcept C123321153 @default.
• W2064232761 hasConcept C126322002 @default.
• W2064232761 hasConcept C143998085 @default.
• W2064232761 hasConcept C2775930923 @default.
• W2064232761 hasConcept C2776694085 @default.
• W2064232761 hasConcept C2777292972 @default.
• W2064232761 hasConcept C2777299880 @default.
• W2064232761 hasConcept C2777909004 @default.
• W2064232761 hasConcept C2778050828 @default.
• W2064232761 hasConcept C2780456651 @default.
• W2064232761 hasConcept C31760486 @default.
• W2064232761 hasConcept C526805850 @default.
• W2064232761 hasConcept C530470458 @default.
• W2064232761 hasConcept C542804219 @default.
• W2064232761 hasConcept C71924100 @default.
• W2064232761 hasConcept C98274493 @default.
• W2064232761 hasConceptScore W2064232761C121608353 @default.
• W2064232761 hasConceptScore W2064232761C123321153 @default.
• W2064232761 hasConceptScore W2064232761C126322002 @default.
• W2064232761 hasConceptScore W2064232761C143998085 @default.
• W2064232761 hasConceptScore W2064232761C2775930923 @default.
• W2064232761 hasConceptScore W2064232761C2776694085 @default.
• W2064232761 hasConceptScore W2064232761C2777292972 @default.
• W2064232761 hasConceptScore W2064232761C2777299880 @default.
• W2064232761 hasConceptScore W2064232761C2777909004 @default.
• W2064232761 hasConceptScore W2064232761C2778050828 @default.
• W2064232761 hasConceptScore W2064232761C2780456651 @default.
• W2064232761 hasConceptScore W2064232761C31760486 @default.

• next